Does early posttreatment surveillance imaging affect subsequent management following stereotactic body radiation therapy for early-stage non-small cell lung cancer?

Practical Radiation Oncology

Volumn 4, Issue 4, 2014, Pages 240-246

  Daly, Megan E ^a   Beckett, Laurel A ^b   Chen, Allen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER REGRESSION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; EARLY CANCER; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG METASTASIS; LUNG NODULE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; STEREOTACTIC BODY RADIATION THERAPY; SYSTEMIC THERAPY; THORAX RADIOGRAPHY; TUMOR GROWTH; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE MANAGEMENT; LUNG NEOPLASMS; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; RADIOSURGERY; TIME TO TREATMENT; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE MANAGEMENT; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOSURGERY; TIME-TO-TREATMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84903731421     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2013.08.006     Document Type: Article

References (20)

1. Timmerman R., Paulus R., Galvin J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303:1070-1076.
2. Baumann P., Nyman J., Hoyer M., et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009, 27:3290-3296.
3. Fakiris A.J., McGarry R.C., Yiannoutsos C.T., et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009, 75:677-682.
4. Chi A., Liao Z., Nguyen N.P., Xu J., Stea B., Komaki R. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol 2010, 94:1-11.
5. Daly M.E., Perks J.R., Chen A.M. Patterns-of-care for thoracic stereotactic body radiotherapy among practicing radiation oncologists in the United States. J Thorac Oncol 2013, 8:202-207.
6. RTOG 0813: Seamless phase I/II study of stereotactic lung radiotherapy (SBRT) for early stage, centrally located, non-small cell lung cancer in medically inoperable patients. Available at: Accessed April 7, 2013. http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0813.
7. RTOG 0915: A randomized phase II study comparing 2 stereotactic body radiation therapy (SBRT) schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer. Available at: Accessed April 7, 2013. http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0915.
8. Bollineni V.R., Widder J., Pruim J., Langendijk J.A., Wiegman E.M. Residual (1)(8)F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control. Int J Radiat Oncol Biol Phys 2012, 83:e551-e555.
9. Nakajima N., Sugawara Y., Kataoka M., et al. Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of (18)F-FDG PET/CT findings. Ann Nucl Med 2013, 27:261-270.
10. Dunlap N.E., Yang W., McIntosh A., et al. Computed tomography-based anatomic assessment overestimates local tumor recurrence in patients with mass-like consolidation after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2012, 84:1071-1077.
11. Zhang X., Liu H., Balter P., et al. Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2012, 83:1558-1565.
12. Ebright M.I., Russo G.A., Gupta A., Subramaniam R.M., Fernando H.C., Kachnic L.A. Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer. J Thorac Cardiovasc Surg 2013, 145:709-715.
13. Colice G.L., Rubins J., Unger M. American College of Chest Physicians. Follow-up and surveillance of the lung cancer patient following curative-intent therapy. Chest 2003, 123(1 Suppl):272S-283S.
14. Network, N.C.C. NCCN clinical practice guidelines in oncology. Non-small cell lung cancer. Version 2.2013. Available at: Accessed August 23, 2013. http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.
15. Pfister D.G., Johnson D.H., Azzoli C.G., et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004, 22:330-353.
16. Rubins J, Unger M, Colice GL; American College of Chest Physicians. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). Chest. 2007;132(3 Suppl):355S-367S.
17. Vansteenkiste J, De Ruysscher D, Eberhardt WE, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [Epub ahead of print]. Ann Oncol. accessed August 23, 2013. doi:10.1093/annonc/mdt241.
18. Wang J., Wu N., Cham M.D., Song Y. Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy. AJR Am J Roentgenol 2009, 193:1090-1096.
19. Mattonen S.A., Palma D.A., Haasbeek C.J., Senan S., Ward A.D. Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes. Acta Oncol 2013, 52:910-918.
20. Trakul N., Harris J.P., Le Q.T., et al. Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors. J Thorac Oncol 2012, 7:1462-1465.